
HPLC Verified
Research Grade
COA Published
PT-141 10mg
PT-141 (Bremelanotide)
CAS: 189691-06-3
Bremelanotide MC1R/MC3R/MC4R agonist. FDA-approved (Vyleesi) for HSDD. CNS-based mechanism distinct from PDE5 inhibition. 99.0% purity.
Price
$69.99
45 in stock
HPLC verified · third-party tested · research use only
Specifications
PT-141 (Bremelanotide) — Research Overview
Bremelanotide MC1R/MC3R/MC4R agonist. FDA-approved (Vyleesi) for HSDD. CNS-based mechanism distinct from PDE5 inhibition. 99.0% purity.
Related Products

GHK-Cu 50mg
Copper Peptide GHK-Cu
Gly-His-Lys copper tripeptide, 50mg. Upregulates collagen I by ~70%, activates SOD and antioxidant enzymes, modulates 4,000+ genes. 99.1% purity.
$50.00
CAS 49557-75-7

GHK-Cu 100mg
Copper Peptide GHK-Cu
Gly-His-Lys copper tripeptide, 100mg. Collagen I, elastin, and antioxidant enzyme gene modulation across 4,000+ gene targets. Extended research supply. 99.1% purity.
$89.99
CAS 49557-75-7
PT-141 10mg
$69.99

